Ea Series Trust Sage Therapeutics, Inc. Transaction History
Ea Series Trust
- $2.84 Trillion
- Q2 2023
A detailed history of Ea Series Trust transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Ea Series Trust holds 57,153 shares of SAGE stock, worth $496,088. This represents 0.09% of its overall portfolio holdings.
Number of Shares
57,153Holding current value
$496,088% of portfolio
0.09%Shares
1 transactions
Others Institutions Holding SAGE
# of Institutions
30Shares Held
6.27MCall Options Held
37.8KPut Options Held
114K-
Black Rock Inc. New York, NY5.22MShares$45.3 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V8599KShares$5.2 Million0.03% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL143KShares$1.24 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V8103KShares$897,5640.0% of portfolio
-
Equitec Proprietary Markets, LLC63.9KShares$554,6520.57% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $516M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...